Feed SCNLF
SC
Scancell Holdings plc SCNLF OTC · Healthcare · United Kingdom
$1.15 +0.00% +$0.00
Summary
No overall score for this company yet.
Valuation -Growth -Profitability -Quality 57Debt 0Stability 26
What speaks for it
- It earns 652 GBP a year on every 100 GBP of invested capital.
What to watch
- It passes only 1 of the 9 points of the Piotroski financial health test.
- For every 100 GBP of bills due within a year it has 28 GBP of short-term assets.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Is it growing?
Revenue (GBP)
202220232024202520262027
Diluted EPS (GBP)
202220232024202520262027
- Analyst estimate
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Over the last 12 months it made a loss of £17.8M.
Profitability in detailIs it financially healthy?
Debt is a burdenCash and short-term investments £5.33M
Debt £17.1M
Free cash flow over 12 months -£10.5M
Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.